Search results for: “ALEX”
-
Alexion Pharmaceuticals Inc Valuation – February 2019 $ALXN
Alexion Pharmaceuticals, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the poor dividend history, and the high PEmg and PB ratios.
-
Alexandria Real Estate Equities Inc Valuation – November 2018 $ARE
Alexandria Real Estate Equities Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability or growth over the last ten years, and the high PEmg ratio.
-
Alexander & Baldwin Inc Valuation – July 2018 $ALEX
Alexander & Baldwin Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the small size, low current ratio, insufficient earnings stability over the last ten years, and the poor dividend history.
-
Alexion Pharmaceuticals Inc Valuation – April 2018 $ALXN
Alexion Pharmaceuticals, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the poor dividend history, and the high PEmg and PB ratios.
-
Alexandria Real Estate Equities Inc Valuation – February 2018 $ARE
Alexandria Real Estate Equities Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the high PEmg ratio.
-
Alexion Pharmaceuticals Inc Valuation – December 2016 $ALXN
Alexion Pharmaceuticals, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability over the last ten years, the poor dividend history, and the high PEmg and PB ratios.
-
Alexander & Baldwin Inc Valuation – December 2016 $ALEX
Alexander & Baldwin Inc does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability over the last ten years, and the poor dividend history, and the high PEmg ratio.
-
Alexandria Real Estate Equities Inc. Analysis – Initial Coverage $ARE
Alexandria Real Estate Equities Inc. does not satisfy the requirements of either the Defensive Investor or the Enterprising Investor. The Defensive Investor is concerned with the insufficient earnings growth over the last ten years, and the high PEmg ratio.
-
Alexander & Baldwin Inc Analysis – Initial Coverage $ALEX
Alexander & Baldwin Inc. is not suitable for the more conservative Defensive Investor or the Enterprising Investor. The Defensive Investor is concerned with the small size, low current ratio, short history, and the high PEmg ratio.
-
Alexion Pharmaceuticals Inc. Analysis – August 2015 Update $ALXN
Alexion Pharmaceuticals Inc. is not suitable for the more conservative Defensive Investor or the Enterprising Investor. The Defensive Investor is concerned with the insufficient earnings growth or stability over the last ten years, the lack of dividends, and the high PEmg and PB ratios.